XML 187 R78.htm IDEA: XBRL DOCUMENT v3.24.0.1
Significant partly-owned subsidiary (Tables)
12 Months Ended
Dec. 31, 2023
Interest In Other Entities [Abstract]  
Disclosure of interests in subsidiaries
The following table shows BCE’s significant subsidiaries at December 31, 2023. BCE has other subsidiaries which have not been included in the table as each represents less than 10% individually and less than 20% in aggregate of total consolidated revenues.
All of these significant subsidiaries are incorporated in Canada and provide services to each other in the normal course of operations. The value of these transactions is eliminated on consolidation.
  OWNERSHIP PERCENTAGE
SUBSIDIARY 2023 2022
Bell Canada 100  % 100  %
Bell Mobility Inc. 100  % 100  %
Bell Media Inc. 100  % 100  %
The following tables show summarized financial information for our subsidiary with significant non-controlling interest (NCI).
Summarized statements of financial position
 
CTV SPECIALTY(1) (2)
FOR THE YEAR ENDED DECEMBER 31 2023 2022
Current assets 466  400 
Non-current assets 941  958 
Total assets 1,407  1,358 
Current liabilities 153  140 
Non-current liabilities 239  246 
Total liabilities 392  386 
Total equity attributable to BCE shareholders 707  678 
NCI 308  294 
(1)At December 31, 2023 and 2022, the ownership interest held by NCI in CTV Specialty Television Inc. (CTV Specialty) was 29.9%. CTV Specialty was incorporated and operated in Canada as at such dates.
(2)CTV Specialty's net assets at December 31, 2023 and 2022 include $7 million and $5 million, respectively, directly attributable to NCI.
 
Selected income and cash flow information
CTV SPECIALTY(1)
FOR THE YEAR ENDED DECEMBER 31 2023 2022
Operating revenues 969  986 
Net earnings 209  180 
Net earnings attributable to NCI 65  57 
Total comprehensive income 196  198 
Total comprehensive income attributable to NCI 61  63 
Cash dividends paid to NCI 47  39 
(1)CTV Specialty's net earnings and total comprehensive income include $3 million and $4 million directly attributable to NCI for 2023 and 2022, respectively.